Canopy Growth Corporation (CGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.65
-4.10%
Mkt Cap $285.85M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$14.47
Range $8.00 – $27.85
Implied Upside
+2133.0%
Consensus $14.47 vs current $0.65